164 related articles for article (PubMed ID: 1571076)
1. Positron emission tomography in degenerative disorders of the dopaminergic system.
Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
[TBL] [Abstract][Full Text] [Related]
2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
3. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
4. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
5. [Functional imaging for disorders of basal ganglia].
Otsuka M; Taniwaki T
Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
[TBL] [Abstract][Full Text] [Related]
6. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
[TBL] [Abstract][Full Text] [Related]
7. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
Karbe H; Grond M; Huber M; Herholz K; Kessler J; Heiss WD
J Neurol; 1992 Feb; 239(2):98-102. PubMed ID: 1552311
[TBL] [Abstract][Full Text] [Related]
8. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
9. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
[TBL] [Abstract][Full Text] [Related]
10. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
Park HK; Kim JS; Im KC; Oh SJ; Kim MJ; Lee JH; Chung SJ; Lee MC
Mov Disord; 2009 Jan; 24(2):237-45. PubMed ID: 18951539
[TBL] [Abstract][Full Text] [Related]
11. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
[TBL] [Abstract][Full Text] [Related]
12. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
Im JH; Chung SJ; Kim JS; Lee MC
J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
[TBL] [Abstract][Full Text] [Related]
13. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
Ghaemi M; Raethjen J; Hilker R; Rudolf J; Sobesky J; Deuschl G; Heiss WD
Mov Disord; 2002 Jul; 17(4):782-8. PubMed ID: 12210876
[TBL] [Abstract][Full Text] [Related]
14. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
15. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Thobois S; Guillouet S; Broussolle E
Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography (PET) in "pure akinesia".
Taniwaki T; Hosokawa S; Goto I; Fujii N; Otsuka M; Kuwabara Y; Ichiya Y; Hasuo K; Kato M
J Neurol Sci; 1992 Jan; 107(1):34-9. PubMed ID: 1578232
[TBL] [Abstract][Full Text] [Related]
17. Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.
Messa C; Volonté MA; Fazio F; Zito F; Carpinelli A; d'Amico A; Rizzo G; Moresco RM; Paulesu E; Franceschi M; Lucignani G
Eur J Nucl Med; 1998 Sep; 25(9):1270-6. PubMed ID: 9724376
[TBL] [Abstract][Full Text] [Related]
18. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
[TBL] [Abstract][Full Text] [Related]
19. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
[TBL] [Abstract][Full Text] [Related]
20. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]